DK165326C - Monoklonale antistoffer mod humanrenin og derivater deraf samt fremgangsmaade til deres fremstilling, hybridoma-cellelinier samt fremgangsmaade til deres fremstilling, anvendelse af de monoklonale antistoffer og deres derivater samt testsaet indeholdende antistofferne og/eller deres derivater - Google Patents

Monoklonale antistoffer mod humanrenin og derivater deraf samt fremgangsmaade til deres fremstilling, hybridoma-cellelinier samt fremgangsmaade til deres fremstilling, anvendelse af de monoklonale antistoffer og deres derivater samt testsaet indeholdende antistofferne og/eller deres derivater

Info

Publication number
DK165326C
DK165326C DK153385A DK153385A DK165326C DK 165326 C DK165326 C DK 165326C DK 153385 A DK153385 A DK 153385A DK 153385 A DK153385 A DK 153385A DK 165326 C DK165326 C DK 165326C
Authority
DK
Denmark
Prior art keywords
antist
derivatives
preparation
monoclonal antibodies
cell lines
Prior art date
Application number
DK153385A
Other languages
Danish (da)
English (en)
Other versions
DK153385A (da
DK153385D0 (da
DK165326B (da
Inventor
Christoph Heusser
Rudolf Heinrich Andreatta
Sefik Alkan
Jeanette Wood
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK153385D0 publication Critical patent/DK153385D0/da
Publication of DK153385A publication Critical patent/DK153385A/da
Publication of DK165326B publication Critical patent/DK165326B/da
Application granted granted Critical
Publication of DK165326C publication Critical patent/DK165326C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/86—Renin inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
DK153385A 1984-04-09 1985-04-03 Monoklonale antistoffer mod humanrenin og derivater deraf samt fremgangsmaade til deres fremstilling, hybridoma-cellelinier samt fremgangsmaade til deres fremstilling, anvendelse af de monoklonale antistoffer og deres derivater samt testsaet indeholdende antistofferne og/eller deres derivater DK165326C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH178184 1984-04-09
CH178184 1984-04-09

Publications (4)

Publication Number Publication Date
DK153385D0 DK153385D0 (da) 1985-04-03
DK153385A DK153385A (da) 1985-10-10
DK165326B DK165326B (da) 1992-11-09
DK165326C true DK165326C (da) 1993-03-29

Family

ID=4218460

Family Applications (1)

Application Number Title Priority Date Filing Date
DK153385A DK165326C (da) 1984-04-09 1985-04-03 Monoklonale antistoffer mod humanrenin og derivater deraf samt fremgangsmaade til deres fremstilling, hybridoma-cellelinier samt fremgangsmaade til deres fremstilling, anvendelse af de monoklonale antistoffer og deres derivater samt testsaet indeholdende antistofferne og/eller deres derivater

Country Status (13)

Country Link
US (1) US4780401A (fr)
EP (1) EP0158599B1 (fr)
JP (2) JPH0669390B2 (fr)
AT (1) ATE57392T1 (fr)
AU (1) AU591870B2 (fr)
CA (1) CA1277261C (fr)
DE (1) DE3580056D1 (fr)
DK (1) DK165326C (fr)
ES (2) ES8707295A1 (fr)
FI (1) FI87933C (fr)
IE (1) IE57956B1 (fr)
NO (1) NO165556C (fr)
ZA (1) ZA852557B (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972990A (en) * 1992-04-10 1999-10-26 Brigham And Women's Hospital, Inc. Methods for reducing risk of repeat myocardial infarction and increasing survival in heart attack victims
AU4250893A (en) * 1992-05-14 1993-12-13 L.R.S. Diagnostics, Inc. Methods and novel proteins associated with low renin syndrome
DE69322847T2 (de) * 1993-01-13 1999-05-27 Idemitsu Kosan Co. Ltd., Tokio/Tokyo Monoklonaler Antikörper gegen menschliches Ceruloplasmin
WO1994020857A1 (fr) * 1993-03-11 1994-09-15 The Regents Of The University Of California Titrage s'appliquant a l'immunite humorale par rapport a des macromolecules
US6911528B1 (en) * 1994-12-02 2005-06-28 The Johns Hopkins University School Of Medicine Hedgehog-derived polypeptides
US20030167483A1 (en) * 1998-06-24 2003-09-04 Farese Robert V. Diacylglycerol O-acyltransferase
WO2002048715A2 (fr) 2000-12-14 2002-06-20 The Brigham And Women's Hospital, Inc. Marqueurs inflammatoires comme outils de detection et de prevention du diabete sucre et comme outils facilitant la selection d'agents s'utilisant dans la prevention et le traitement du diabete
DK3072978T3 (en) 2002-05-09 2018-09-17 Brigham & Womens Hospital Inc : 1L1RL-1 AS A CARDIOVASCULAR DISEASE MARKER
AU2003229016A1 (en) * 2002-05-10 2003-11-11 The Trustees Of Columbia University In The City Of New York Genetically engineered cell lines and systems for propagatingvaricella zoster virus and methods of use thereof
JP2007502831A (ja) * 2003-08-20 2007-02-15 ニトロメッド インコーポレーティッド ニトロソ化およびニトロシル化心血管化合物、組成物、ならびに使用方法
CA2536975A1 (fr) * 2003-08-28 2005-03-17 Nitromed, Inc. Composes diuretiques nitroses et nitrosyles, compositions et procedes d'utilisation correspondants
SI2384753T1 (sl) 2003-08-29 2016-06-30 The Brigham And Women's Hospital, Inc. Hidantoinski derivati kot inhibitorji celične nekroze
EP2306192B1 (fr) 2003-12-05 2015-10-14 The Cleveland Clinic Foundation Marqueurs de risque pour maladies cardiovasculaires
CA2554716A1 (fr) * 2004-01-22 2005-08-04 Nitromed, Inc. Composes nitroses et/ou nitrosyles, compositions et procede pour les utiliser
US7803838B2 (en) * 2004-06-04 2010-09-28 Forest Laboratories Holdings Limited Compositions comprising nebivolol
US8067464B2 (en) 2004-10-04 2011-11-29 Nitromed, Inc. Compositions and methods using apocynin compounds and nitric oxide donors
US9164104B2 (en) 2004-10-06 2015-10-20 The Brigham And Women's Hospital, Inc. Relevance of achieved levels of markers of systemic inflammation following treatment
CA2574535A1 (fr) * 2004-11-15 2006-05-26 Nitromed, Inc. Composes diuretiques comprenant des groupes donneurs d'oxyde nitrique heterocycliques, compositions et methodes d'utilisation
US20080306041A1 (en) * 2005-01-21 2008-12-11 Garvey David S Cardiovascular Compounds Comprising Heterocyclic Nitric Oxide Donor Groups, Compositions and Methods of Use
WO2006083779A2 (fr) * 2005-01-31 2006-08-10 Mylan Laboratories, Inc. Metabolites de nebivolol hydroxyles
EP1858525A2 (fr) * 2005-02-16 2007-11-28 Nitromed, Inc. Sels donneurs d oxyde nitrique organique de composes antimicrobiens et composes et procedes d utilisation
JP2008531697A (ja) * 2005-02-28 2008-08-14 ニトロメッド インコーポレーティッド 酸化窒素増強基を含む心血管化合物、組成物および使用法
CA2597444A1 (fr) * 2005-03-09 2006-09-21 Nitromed, Inc. Sels organiques d'antagonistes de l'angiotensine ii augmentant le taux de monoxyde d'azote endogene, compositions et procedes d'utilisation correspondants
AP2896A (en) 2005-05-31 2014-05-31 Mylan Lab Inc Compositions comprising nebivolol
WO2007016677A2 (fr) 2005-08-02 2007-02-08 Nitromed, Inc. Composes antimicrobiens promoteurs d'oxyde nitrique, compositions et procedes d'utilisation
WO2007041681A2 (fr) * 2005-10-04 2007-04-12 Nitromed, Inc. Méthodes de traitement de troubles respiratoires
US8119358B2 (en) 2005-10-11 2012-02-21 Tethys Bioscience, Inc. Diabetes-related biomarkers and methods of use thereof
US7838023B2 (en) * 2005-11-16 2010-11-23 Nitromed, Inc. Furoxan compounds, compositions and methods of use
WO2007075541A2 (fr) * 2005-12-20 2007-07-05 Nitromed, Inc. Composes a l'acide glutamique activateurs d'oxyde nitrique, compositions et procedes d'utilisation
WO2007075542A2 (fr) * 2005-12-22 2007-07-05 Nitromed, Inc. Composes au pyruvate activateurs d'oxyde nitrique, compositions et procedes d'utilisation
EP2302395B1 (fr) 2006-06-07 2015-04-15 Health Diagnostic Laboratory, Inc. Marqueurs associés aux événements artériovasculaires et procédés d'utilisation correspondants
US7897360B2 (en) * 2006-12-15 2011-03-01 Kimberly-Clark Worldwide, Inc. Enzyme detection techniques
TW200849035A (en) 2007-04-18 2008-12-16 Tethys Bioscience Inc Diabetes-related biomarkers and methods of use thereof
US7828840B2 (en) * 2007-11-15 2010-11-09 Med Institute, Inc. Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists
GB2460915B (en) 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
TW201201764A (en) 2010-02-01 2012-01-16 Hospital For Sick Children Remote ischemic conditioning for treatment and prevention of restenosis
KR20130040851A (ko) 2010-03-31 2013-04-24 더 호스피탈 포 식 칠드런 심근 경색 후 결과를 개선시키기 위한 원격 허혈 처치의 사용
US9265772B2 (en) 2012-05-11 2016-02-23 Reset Therapeutics, Inc. Carbazole-containing sulfonamides as cryptochrome modulators
ES2786506T3 (es) 2012-08-01 2020-10-13 Zahra Tavakoli Composiciones congeladas fluidas que comprenden un agente terapéutico
US9725452B2 (en) 2013-03-15 2017-08-08 Presidents And Fellows Of Harvard College Substituted indoles and pyrroles as RIP kinase inhibitors
TWI690521B (zh) 2014-04-07 2020-04-11 美商同步製藥公司 作為隱花色素調節劑之含有咔唑之醯胺類、胺基甲酸酯類及脲類
JP6836748B2 (ja) * 2016-10-21 2021-03-03 富士レビオ株式会社 レニン濃度の免疫学的測定法
CN107007849A (zh) * 2017-06-19 2017-08-04 河北省人民医院 一种建立甲减性心功能不全大鼠动物模型的方法
CN118725125B (zh) * 2023-03-30 2025-08-08 东莞市朋志生物科技有限公司 抗肾素抗体、检测肾素的试剂和试剂盒
CN118772283B (zh) * 2023-04-07 2025-09-16 东莞市朋志生物科技有限公司 抗肾素抗体、检测肾素的试剂和试剂盒

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies

Also Published As

Publication number Publication date
IE850876L (en) 1985-10-09
AU4088685A (en) 1985-10-17
ES8707295A1 (es) 1987-07-16
US4780401A (en) 1988-10-25
ES542017A0 (es) 1987-07-16
DE3580056D1 (de) 1990-11-15
DK153385A (da) 1985-10-10
NO165556B (no) 1990-11-19
FI851334A0 (fi) 1985-04-03
ES8802254A1 (es) 1988-04-16
DK153385D0 (da) 1985-04-03
JPS6485070A (en) 1989-03-30
FI851334L (fi) 1985-10-10
CA1277261C (fr) 1990-12-04
NO165556C (no) 1991-02-27
EP0158599A2 (fr) 1985-10-16
ZA852557B (en) 1985-11-27
ATE57392T1 (de) 1990-10-15
JPS60231624A (ja) 1985-11-18
EP0158599A3 (en) 1987-12-16
JPH0669371B2 (ja) 1994-09-07
AU591870B2 (en) 1989-12-21
FI87933C (fi) 1993-03-10
FI87933B (fi) 1992-11-30
DK165326B (da) 1992-11-09
JPH0669390B2 (ja) 1994-09-07
IE57956B1 (en) 1993-05-19
NO851384L (no) 1985-10-10
ES557016A0 (es) 1988-04-16
EP0158599B1 (fr) 1990-10-10

Similar Documents

Publication Publication Date Title
DK165326C (da) Monoklonale antistoffer mod humanrenin og derivater deraf samt fremgangsmaade til deres fremstilling, hybridoma-cellelinier samt fremgangsmaade til deres fremstilling, anvendelse af de monoklonale antistoffer og deres derivater samt testsaet indeholdende antistofferne og/eller deres derivater
DK572487D0 (da) Fremgangsmaade til fremstilling af human vaekstfaktor fra endotheliale celler
DK98192A (da) Triphenylmethyl-derivater af sn-glycero-3-phosphocholin og sn-glycero-3-phosphoethanolamin og fremgangsmaade til fremstilling deraf
ATE70310T1 (de) Verfahren zur herstellung von monoklonalen antikoerpern gegen hbsag.
ES557072A0 (es) Procedimiento para la obtencion de lineas celulares de hibridoma
ES8605812A1 (es) Procedimiento para obtener un preparado de factor xiii
SE7906273L (sv) Sett att framstella en gammaglobulinlosning
DK12388A (da) Sialosylcholesterol, fremgangsmaade til fremstilling af og neuropatimiddel omfattende samme
SE8404334D0 (sv) 16-fluoro-16,17-didehydro-prostanoids and process for their preparation
DK299585D0 (da) Fremgangsmaade til behandling af syreholdige afgangsgasser
FI851969A7 (fi) Korkean verenpaineen hoitoon soveltuvia tetrahydronaftalenoleja.
DK380785D0 (da) S-6-fluor-4-aminochroman-4-carboxylsyre-forbindelser og salte deraf, fremgangsmaade til fremstilling deraf og anvendelse deraf til fremstilling af sorbinil
FI931988L (fi) Menetelmä terapeuttisesti aktiivisten fosfopeptidien valmistamiseksi
ATE78513T1 (de) Immunoglobulin-a-rezeptor-protein (arp), sowie dessen klonierung und expression.
DK45783D0 (da) Production and characterzation of hybridoma antibodies directed specifically against common determinant(s) present among closely related, but distinct proteins

Legal Events

Date Code Title Description
PBP Patent lapsed
PBP Patent lapsed